PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Bio-Rad Laboratories Inc (BIO-B)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS0905721082
CUSIP090572108
SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap$7.98B
EPS-$21.83
PEG Ratio1.21
Revenue (TTM)$2.67B
Gross Profit (TTM)$1.57B
EBITDA (TTM)$511.60M
Year Range$271.00 - $387.55
Short %0.01%
Short Ratio0.58

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Bio-Rad Laboratories Inc

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Bio-Rad Laboratories Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


5,000.00%10,000.00%15,000.00%December2024FebruaryMarchApril
12,818.72%
2,928.56%
BIO-B (Bio-Rad Laboratories Inc)
Benchmark (^GSPC)

S&P 500

Returns By Period

Bio-Rad Laboratories Inc had a return of -12.71% year-to-date (YTD) and -40.18% in the last 12 months. Over the past 10 years, Bio-Rad Laboratories Inc had an annualized return of 6.66%, while the S&P 500 had an annualized return of 10.64%, indicating that Bio-Rad Laboratories Inc did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-12.71%7.50%
1 month-15.74%-1.61%
6 months2.53%17.65%
1 year-40.18%26.26%
5 years (annualized)-0.98%11.73%
10 years (annualized)6.66%10.64%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-1.04%2.95%1.70%
2023-23.11%12.41%4.49%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BIO-B is 14, indicating that it is in the bottom 14% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of BIO-B is 1414
Bio-Rad Laboratories Inc(BIO-B)
The Sharpe Ratio Rank of BIO-B is 77Sharpe Ratio Rank
The Sortino Ratio Rank of BIO-B is 1313Sortino Ratio Rank
The Omega Ratio Rank of BIO-B is 11Omega Ratio Rank
The Calmar Ratio Rank of BIO-B is 5050Calmar Ratio Rank
The Martin Ratio Rank of BIO-B is 00Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Bio-Rad Laboratories Inc (BIO-B) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


BIO-B
Sharpe ratio
The chart of Sharpe ratio for BIO-B, currently valued at -0.88, compared to the broader market-2.00-1.000.001.002.003.004.00-0.88
Sortino ratio
The chart of Sortino ratio for BIO-B, currently valued at -1.01, compared to the broader market-4.00-2.000.002.004.006.00-1.01
Omega ratio
The chart of Omega ratio for BIO-B, currently valued at 0.62, compared to the broader market0.501.001.500.62
Calmar ratio
The chart of Calmar ratio for BIO-B, currently valued at 0.08, compared to the broader market0.002.004.006.000.08
Martin ratio
The chart of Martin ratio for BIO-B, currently valued at -3.35, compared to the broader market-10.000.0010.0020.0030.00-3.35
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.17, compared to the broader market-2.00-1.000.001.002.003.004.002.17
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.11, compared to the broader market-4.00-2.000.002.004.006.003.11
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.501.001.501.38
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.65, compared to the broader market0.002.004.006.001.65
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.41, compared to the broader market-10.000.0010.0020.0030.008.41

Sharpe Ratio

The current Bio-Rad Laboratories Inc Sharpe ratio is -0.88. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Bio-Rad Laboratories Inc with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchApril
-0.88
2.00
BIO-B (Bio-Rad Laboratories Inc)
Benchmark (^GSPC)

Dividends

Dividend History


Bio-Rad Laboratories Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2024FebruaryMarchApril
-65.81%
-2.49%
BIO-B (Bio-Rad Laboratories Inc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Bio-Rad Laboratories Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Bio-Rad Laboratories Inc was 68.36%, occurring on Dec 23, 1993. Recovery took 106 trading sessions.

The current Bio-Rad Laboratories Inc drawdown is 65.81%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-68.36%Feb 17, 1987638Dec 23, 1993106May 11, 1995744
-66.89%Sep 13, 2021141Oct 27, 2023
-50.14%Aug 12, 200890Mar 5, 2009138Apr 20, 2010228
-47.28%Jun 12, 1996128Jan 15, 199987Jan 25, 2001215
-36.87%May 30, 198652Sep 17, 198667Jan 15, 1987119

Volatility

Volatility Chart

The current Bio-Rad Laboratories Inc volatility is 20.44%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%December2024FebruaryMarchApril
20.44%
3.39%
BIO-B (Bio-Rad Laboratories Inc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Bio-Rad Laboratories Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items